Table 5 Different trials of Xience DES
From: Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach
Trial Name | Stents | Duration | Stent Thrombosis Rate (%) | Reference |
|---|---|---|---|---|
ABSIRB II | BVS vs. Xience (n = 501) | 4 years | 2.8 vs. 0 | [41] |
ABSORB China | BVS vs Xience (n = 480) | 2 years | 0.9 vs. 0.0 | [42] |
STOPDAPT | Xience (n = 1522) | 1 year | 0 | [43] |
TWENTE | Endeavor Resolute vs Xience (n = 1391) | 1 year | 0.58% and 0% (p = 0.12) | [44] |